Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Multicentric Study, 140 Patients Suffering of Meibomian Glands Dysfunction.

NCT01189474 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT01189474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01189474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Multicentric Study, 140 Patients Suffering of Meibomian Glands Dysfunction.
Lead sponsor
Laboratoires Thea
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2011
Enrollment
104 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

eyelid diseases